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Anaplastic lymphoma kinase (ALK) negative anaplastic large cell lymphoma (ALCL) is a rare type of non-
Hodgkin’s lymphoma (NHL). Pulmonary inﬁltration with multiple nodules is an unusual manifestation.
We present an adult patient who had diffuse lung and bone marrow involvement and review the
pulmonary manifestation of ALCL. The present reports suggest that diffuse lung inﬁltration is associated
with a bad clinical outcome.
 2009 Elsevier Ltd. All rights reserved.1. Case
A 70-year-old male ex-smoker presented with fever accompa-
nied by night sweats for six days. His temperature could reach up to
38.2 C. He also reported 5 kg of weight loss within one month. He
did not have chills, cough, sputum, hemoptysis, skin rash or
arthralgia. He denied recent travel, exposure to allergens or close
contact with patients with tuberculosis. He was used to be healthy
and was on no medication. On examination, the patient had
a temperature of 37.5 C, BP of 120/70 mmHg, pulse rate of 90 bpm,
and respiratory rate of 24 bpm. Chest auscultation revealed diffuse
faint rhonchi. No lymphadenopathy, subcutaneous nodules or
hepatosplenomegaly were noted. The remainder of the physical
examination was unremarkable.
A CBC showed a normal WBC count (4.56109 cells/L), with
a slight increase in percentage of lymphocytes (46.5%). The eryth-
rocyte sedimentation rate was 30 mm/h. The serum level of C-
reactive protein was elevated at 51 mg/L. Other laboratory workup
including urinalysis, liver and renal function and electrolytes were
normal. Blood cultures were sterile. A chest radiography (Fig. 1)
demonstrated bilateral nodular opacities predominantly in the
lower lung ﬁelds. Right hilum was prominent. Computed tomog-
raphy (CT) of thorax revealed diffuse nodules and marked thick-
ening of bronchovascular bundles and interlobular septae, withUniversity First Hospital, No.
hina. Tel.: þ86 01083572211;
rved.signiﬁcant mediastinal and hilar lymphadenopathy (Fig. 2a and b).
Broad-spectrum antibiotics were initiated on hospital admission.
However, the patient’s condition deteriorated and he developed
hypoxemic respiratory failure (PaO2 was 56.5 mmHg on room air)
one week after admission.
Subsequent bronchoscopy detected no abnormalities. Microbi-
ology studies of bronchoalveolar lavage (BAL) ﬂuid were all nega-
tive, including acid-fast bacilli stains. The cellular analysis of BAL
ﬂuid demonstrated slightly elevated proportion of lymphocytes
(13%). The transbronchial lung biopsy showed poorly differentiated
malignant cells in multi-focal distribution (Fig. 3). Immunohisto-
chemical stains for epithelial markers and CD20 were all negative,
but those for LCA, CD3 and CD45RO were strong positive, in
accordance with T-cell NHL. Therefore, bone marrow biopsy was
performed and showed patchy inﬁltration by a mixture of small
lymphocytes and large anaplastic lymphoid cells with CD30
expression (Fig. 4), inwhich the large anaplastic cells were negative
for ALK.
Chemotherapy with CHOP (cyclophosphamide, doxorubicin,
vindesine and prednisone) regimen was then administered.
Follow-up imaging demonstrated reduction in number and size of
nodules and lymphadenopathy after ﬁrst cycle of treatment. He is
now under hematologists’ care and to be received further
treatment.
2. Discussion
ALCL is CD30þ T-cell or null-cell NHL, which consists of primary
(systemic and cutaneous ALCLs) and secondary (anaplastic
Fig. 2. Computed tomography of thorax; sections from (a) lung window and (b)
mediastinal window.
Fig. 3. Photomicrograph (hematoxylin–eosin staining, 100) of a lung biopsy spec-
imen taken through bronchoscopy.
Fig. 1. Chest X-ray.
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systemic ALCL accounts for 10–15% of NHL cases in children and
adolescents, whereas only 3% in adults.1 ALCL is found to be asso-
ciated with the t(2;5) translocation, which results in the expression
of ALK protein.2 50–60% of primary systemic ALCLs express ALK
protein. ALCL occurs preferentially in the sinusoids of lymph nodes,
but can also be found in extranodal sites. In a large study, lung
involvement happened in only 11% of ALCL.3 The extranodal
involvement in ALK-negative ALCL is even rare.
With regards to pulmonary involvement of ALCL, two patterns,
the primary (very rare) and secondary pulmonary ALCL have been
described. Primary pulmonary ALCL is deﬁned as clonal lymphoid
proliferation affecting one or both lungs (parenchyma and/or
bronchi) in a patient with no detectable extrapulmonary involve-
ment at diagnosis or during the subsequent 3 months.4 More often
than not, lung is a site of secondary involvement in systemic ALCL.
In some cases, the primary or secondary pulmonary ALCL is almost
indistinguishable in view of the potential involvement of medias-
tinal lymph nodes.
To the best of our knowledge, only 22 cases of primary pulmo-
nary ALCL have been reported, including 4 children and 18 adults
without prominent gender preponderance.4–9 Radiographic
features include endobronchial or intracheal mass (9/22), nodulesFig. 4. Bone marrow biopsy showed inﬁltration of CD30-positive large anaplastic cells
(CD30 immunostaining, 400).
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tations (1/22) and cystic lesions (1/22). (Detailed description of
chest radiography in 7 cases is unavailable.) Among 8 cases that had
ALK staining, 3 cases are ALK-negative ALCL.
There are few radiographic studies on secondary pulmonary
ALCL. Case series about diffuse lung involvement of systemic ALCL
were reported. Close reported a case with ALCL pulmonary
involvement mimicking miliary tuberculosis.10 Postmortem
examination revealed extensive involvement of the heart, liver,
kidneys, stomach, bone marrow and lymph nodes. 15 cases of ALCL
with leukemic phase were reported by now and among them, 9
cases have diffuse lung involvement and 4 cases have pleural
effusion.11,12 In two pediatric ALCL cases, diffuse lung inﬁltrates,
mediastinal adenopathy and hemophagocytosis were presented.13
The outcomes of all these cases were poor. A large study has
concluded that ALK-positive ALCL had a far better 5-year overall
survival rate (70%) than that of ALK-negative one (49%), ALK is
therefore regarded as an important prognostic indicator.14 Inter-
estingly, all the above reports with diffuse lung involvement are
ALK-positive, indicating that diffuse lung inﬁltration is also one of
unfavorable prognostic factors.
In summary, we present a rare case of ALK-negative ALCL with
fever, diffuse pulmonary nodules and rapid progression to respi-
ratory failure. Timely biopsy is crucial for diagnosis and appropriate
management. Although the patient might respond to chemo-
therapy at some point, in general, diffuse pulmonary involvement
heralded unfavorable outcome.Conﬂict of interest
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